AIM ImmunoTech Inc. (AIM)
NYSE: AIM · Biological Products, (No Diagnostic Substances) · Ocala, FL · filing with the SEC since 1996
Who owns AIM ImmunoTech Inc.
As filed with the SECHolders of 5% or more
1
Orca Capital AG holds 9.9% of Common Stock, par value $0.001 per share, as its SCHEDULE 13G filed May 12, 2026 says.
Directors and officers
2
report now, of 13 people on the record since 2007. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 1 named at left.
Holders of 5% or moreshare of the class, as filed
Orca Capital AG
SCHEDULE 13G · filed May 12, 2026 · Common Stock, par value $0.001 per share
Armistice Capital, LLC
SCHEDULE 13G/A · filed Feb 14, 2025 · Common Stock, par value $0.001 per share · reported falling below 5%
Todd Deutsch
SCHEDULE 13D/A · filed Dec 23, 2024 · Common Stock, par value $0.001 per share · reported falling below 5%
Mitchell P. Kopin
SCHEDULE 13G · filed May 27, 2026 · Common stock, par value $0.001 per share · reported falling below 5%
What AIM reports owning in othersstakes of 5% or more, and other ties
Other ties the annual report names
Alcami
An entity · legal entity · owns, named in the 10-K filed Mar 27, 2026
Alliance Global Partners, LLC
An entity · legal entity · owns, named in the 10-K filed Mar 27, 2026
Amarex Clinical Research LLC
An entity · legal entity · owns, named in the 10-K filed Mar 27, 2026
Atlas Sciences LLC
An entity · legal entity · owns, named in the 10-K filed Mar 27, 2026
Maxim Group LLC
An entity · legal entity · owns, named in the 10-K filed Mar 27, 2026
Insider tradesForm 4
0sales
10purchases
0sales on a scheduled plan
0people selling
$0sold, in dollars
$0bought, in dollars
Open-market trades on Form 4 from Nov 12, 2025 to Nov 12, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
2026 runs to Nov 12, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window1 of 13 on the roster
| Person | Role as filed | Sales | Sold | On a plan | Buys | Bought |
|---|---|---|---|---|---|---|
| Equels Thomas K. | CEO & President | 0 | $0 | 0 | 10 | $0 |